LP02 + LF10
Blend
On this page
Gynecology
Bacterial vaginosis
Functionality
Supports vaginal health
Supports treatment of bacterial vaginosis
Dosage / Clinical Study
1) LP02 500 million CFU + LF10 500 million CFU + GOS
Available Formats
Blend
Finished dosage form
Scientific Support
Clinical studies
1) Murina F. et al. Thymol, eugenol and Lactobacilli in a medical device for the treatment of bacterial vaginosis and vulvovaginal candidiasis. New Microbiol. 2018 Jul;41(3):220-224.
In vitro studies
a) Mogna L. et al. Assessment of the In Vitro Inhibitory Activity of Specific Probiotic Bacteria Against Different Escherichia coli strains. J. Clin. Gastroenterol. 2012;46 Suppl.S29-32. Doi: 10.1097/MCG.0b013e31826852b7
